These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2373339)

  • 1. [Late para-aortic recurrence of dysgerminoma].
    Meier W; Meyer G
    Geburtshilfe Frauenheilkd; 1990 May; 50(5):414-6. PubMed ID: 2373339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dysgerminoma of the ovary--a clinical report of 27 patients].
    Hou YJ; Liu LY
    Zhonghua Zhong Liu Za Zhi; 1987 Jul; 9(4):311-4. PubMed ID: 3678024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysgerminoma: the role of conservative surgery.
    Casey AC; Bhodauria S; Shapter A; Nieberg R; Berek JS; Farias-Eisner R
    Gynecol Oncol; 1996 Dec; 63(3):352-7. PubMed ID: 8946871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adjuvant chemotherapy in dysgerminoma].
    Fechtig A; de Dycker RP; Schumacher T; Neumann RL
    Geburtshilfe Frauenheilkd; 1991 May; 51(5):398-400. PubMed ID: 1869011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dysgerminoma of the ovary: a clinical retrospective analysis of 60 cases].
    Zhang R; Hong W; Li S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):550-2. PubMed ID: 8556917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian dysgerminoma associated with fibrosarcoma: a case report.
    Alvarado-Cabrero I; Valencia-Cedillo R; Mohs-Alfaro M; De Anda-González J
    Int J Gynecol Pathol; 2011 Sep; 30(5):466-9. PubMed ID: 21804387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dysgerminoma of the ovary. An analysis of 30 cases].
    Krommer K; Csaba I; Keller G
    Zentralbl Gynakol; 1988; 110(7):413-8. PubMed ID: 3394440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary.
    Kasenda B; Harter P; Hirsch T; Ast A; Buhrmann C; Glaser F; Du Bois A
    Acta Obstet Gynecol Scand; 2009; 88(11):1288-90. PubMed ID: 19900144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure dysgerminoma of the ovary 35 years on: a single institutional experience.
    Vicus D; Beiner ME; Klachook S; Le LW; Laframboise S; Mackay H
    Gynecol Oncol; 2010 Apr; 117(1):23-6. PubMed ID: 20097412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature.
    Jeyakumar A; Cabeza R; Hindenburg A
    Gynecol Oncol; 2001 May; 81(2):314-7. PubMed ID: 11330968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late relapse of ovarian dysgerminoma: case report and literature review.
    Bekaii-Saab T; Einhorn LH; Williams SD
    Gynecol Oncol; 1999 Jan; 72(1):111-2. PubMed ID: 9889041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A rare teratoma of the retroperitoneum].
    Maurer F
    Chirurg; 1988 Jan; 59(1):56-8. PubMed ID: 3349870
    [No Abstract]   [Full Text] [Related]  

  • 14. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rare malignant tumors of the ovaries in adolescents--clinical aspects in deciding therapeutic aggressiveness].
    Schröder W; Bau O
    Zentralbl Gynakol; 1990; 112(10):633-40. PubMed ID: 2402968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dysgerminomas. Clinical aspects, therapy and prognosis with reference to the cooperative therapy study MAIKEI 83/86 for non-testicular germ cell tumors of the Society of Pediatric Oncology].
    Göbel U; Bamberg M; Calaminus G; Jürgens H; Pelzer V; Simon WE; Terruhn V; Wolf A; Mecke H; Harms D
    Geburtshilfe Frauenheilkd; 1989 Aug; 49(8):737-42. PubMed ID: 2792708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of subdiaphragmatic lymph node metastases of primary testicular seminoma (stage II)].
    Gardani G; Lattuada A; Valvo F
    Radiol Med; 1989; 77(1-2):104-14. PubMed ID: 2928559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful chemotherapy in undescended testicular and extragonadal germ cell tumors: report of 2 cases].
    Imamura T; Unoki T; Tamura K; Seita M; Shibata K
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2658-62. PubMed ID: 2427033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes.
    Uzan C; Morice P; Rey A; Pautier P; Camatte S; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
    Ann Surg Oncol; 2004 Jul; 11(7):658-64. PubMed ID: 15197013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of ovarian germ cell tumors.
    Williams SD
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1261-9. PubMed ID: 1663943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.